Based on our results, the suspected beneficial effect of 5‐HT4d on Alzheimer disease development is expected to be amplified in cells co‐expressing either GPRIN2 or GPR37. Here, GPRIN2 is linked to early-onset autosomal dominant Alzheimer disease.